The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

The Trump administration is moving forward with the defense of a Biden-era plan that allows Medicare to negotiate drug prices ...

Lawyers for the government gave the first substantive signal that the Trump administration will continue to defend Medicare ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...

U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...

President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...